首页 | 本学科首页   官方微博 | 高级检索  
检索        

药品生产企业分级分类管理之探讨
引用本文:王宗敏.药品生产企业分级分类管理之探讨[J].中国药事,2009,23(2):107-108.
作者姓名:王宗敏
作者单位:江苏省食品药品监督管理局,南京,210008
摘    要:目的构建安全可靠的社会环境和竞争有序的市场环境。方法从信用体系建设、质量风险管理和监管资源整合的角度,提出对药品生产企业实行分级分类监管的基本构想。结果与结论建立长效监管机制和保障体系,科学有效地实施监管,提高监管能力和效率。

关 键 词:药品生产企业  信用体系  质量风险  分级分类管理

Discussion on Classification Administration to Drug Manufacturers
Wang Zongming.Discussion on Classification Administration to Drug Manufacturers[J].Chinese Pharmaceutical Affairs,2009,23(2):107-108.
Authors:Wang Zongming
Institution:Wang Zongming (Jiangsu Food and Drug Administration, Nanjing 210008)
Abstract:Objective To build a safe and secure social environment and competitive and orderly market environment. Methods From the conformity view of the credit system, the quality of risk management and regulatory resources, to put forward on blueprint of classification administration to the manufacturers. Results and Conclusions To establish a long-term supervision mechanism and security system, to implement the scientific and effective administration and to improve monitoring capacity and efficiency.
Keywords:drug manufacturer  credit system  quality risk  classification administration
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号